Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia

Article English OPEN
Esposito, Susanna; Garziano, Micaela; Rainone, Veronica; Trabattoni, Daria; Biasin, Mara; Senatore, Laura; Marchisio, Paola; Rossi, Marta; Principi, Nicola; Clerici, Mario;
  • Publisher: BioMed Central
  • Journal: Journal of Translational Medicine,volume 13,issue 1 (issn: 1479-5876, eissn: 1479-5876)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC4559022, doi: 10.1186/s12967-015-0649-z
  • Subject: Pidotimod | Settore MED/04 - Patologia Generale | Biochemistry, Genetics and Molecular Biology(all) | Children | Medicine(all) | Community-acquired pneumonia | Immunomodulatory activity | Immunostimulants | Respiratory tract infection | Children; Community-acquired pneumonia; Immunomodulatory activity; Immunostimulants; Pidotimod; Respiratory tract infection; Biochemistry, Genetics and Molecular Biology (all); Medicine (all) | Research | Settore MED/38 - Pediatria Generale e Specialistica

Background Several attempts to improve immune function in young children have been made and encouraging results have been collected with pidotimod (PDT), a synthetic dipeptide molecule that seems to have immunomodulatory activity on both innate and adaptive responses. U... View more
  • References (33)
    33 references, page 1 of 4

    1. Principi N, Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, et al. Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. J Chemother. 2003;15:53-9.

    2. Patria F, Longhi B, Tagliabue C, Tenconi R, Ballista P, Ricciardi G, et al. Clinical profile of recurrent community-acquired pneumonia in children. BMC Pulm Med. 2013;13:60.

    3. Ewing P, Otczyk DC, Occhipinti S, Kyd JM, Gleeson M, Cripps AW. Developmental profiles of mucosal immunity in pre-school children. Clin Dev Immunol. 2010;2010:196785.

    4. Marodi L. Innate cellular immune responses in newborns. Clin Immunol. 2006;118:137-44.

    5. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379-90.

    6. Vigano A, Esposito S, Arienti D, Zagliani A, Massironi E, Principi N, et al. Diefrential development of type 1 and type 2 cytokines and betachemokines in the ontogeny of healthy newborns. Biol Neonate. 1999;75:1-8.

    7. Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJ, Furman D, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160:37-47.

    8. Notarangelo LD. Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling. Curr Opin Immunol. 2014;31:97-101.

    9. Tomlinson G, Chimalapati S, Pollard T, Lapp T, Cohen J, Camberlein E, et al. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol. 2014;193:3736-45.

    10. Labuda LA, de Jong SE, Meurs L, Amoah AS, Mbow M, Ateba-Ngoa U, et al. Diefrences in innate cytokine responses between European and African children. PLoS One. 2014;9:e95241.

  • Related Research Results (1)
  • Related Organizations (2)
  • Metrics